Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy

Journal of Neuro-Oncology

Volumn 59, Issue 2, 2002, Pages 135-142

  Kageji, Teruyoshi ^a   Nagahiro, Shinji ^a   Otersen, Birte ^b   Gabel, Detlef ^b   Nakaichi, Manekazu ^c   Nakagawa, Yoshinobu ^d  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF BREMEN   (Germany)

^c YAMAGUCHI UNIVERSITY   (Japan)

^d National Hospital Organization   (Japan)

Author keywords

Biodistribution; Boron neutron capture therapy; Boron uptake; BSH; Immunohistochemistry

Indexed keywords

BOROCAPTATE; BORON; BORON 10; CHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BINDING; DRUG DISTRIBUTION; DRUG INFUSION; DRUG SELECTIVITY; DRUG TISSUE LEVEL; DRUG UPTAKE; ENDOCYTOSIS; EUROPE; EXTRACELLULAR SPACE; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HEMISPHERE; IMMUNOHISTOCHEMISTRY; JAPAN; NEUTRON CAPTURE THERAPY; NONHUMAN; RAT;

ANIMALS; BOROHYDRIDES; BORON; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; GLIOMA; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; NEOPLASM TRANSPLANTATION; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS; SULFHYDRYL COMPOUNDS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0036713784     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019688515204     Document Type: Article

References (26)

1. Introduction
2. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds
3. Supplementary pharmacological study between 1972 and 1977 on purified mercaptoundecahydrododecaborate
4. Capillary permeability and boron distribution in ethylnitrosourea-induced rat glioma
5. Boron-10-mercaptoundecahydrododecarbonate distribution in rat brain tumours
6. Boron neutron capture therapy of a rat glioma
7. Uptake of boron into human gliomas of athymic mice and into syngenic cerebral gliomas of rat after intracarotid infusion of sulfhydryl boranes
8. Boron uptake by human brain tumors and quality control of boron compounds
9. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy
10. Boron neutron capture therapy: Clinical brain tumor study
11. 11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT)
12. 11SH in patients with glioblastoma
13. Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors
14. Present status and perspectives of boron neutron capture therapy
15. Interaction of mercaptoundecahydrododecarborate (BSH) with phosphatidylcholine in boron neutron capture therapy
16. Quantitative neutron capture radiography for studying the biodistribution of tumor-seeking boron containing compounds
17. Boron-10-mercaptoundecahydodecaborate distribution in human brain tumors as studied by neutron-induced alpha-autoradiography
18. 11SH
19. Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: A basis for boron neutron capture therapy
20. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations
21. 11SH, at subcellular resolution in tissue culture using ion microscopy
22. Quantitative imaging of boron from BPA and BSH in glioblastoma cells with ion microscopy
23. 11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy
24. 11SH) with time interval from BSH infusion in patients with malignant glioma
25. 11SH) in patients with intracranial tumors
26. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma